E-LIB Suche - Ergebnisse für: Strickler, John H.

1

Trastuzumab-Deruxtecan: Redefining HER2 as a Tumor Agnostic..:

Zouein, Joseph ; Karam, Elias ; Strickler, John H..
Targeted Oncology. , 2024

Link: https://doi.org/10.1007/..

2

A Study to Learn how Well Tucatinib Plus Trastuzumab Works ..:

Strickler, John H ; Bekaii-Saab, Tanios S
Future Oncology. 20 (2024) 8 - p. 409-421 , 2024

Link: https://doi.org/10.2217/..

3

Racial and ethnic disparities in genomic testing among lung..:

Meernik, Clare ; Raveendran, Yadurshini ; Kolarova, Michaela...
JNCI: Journal of the National Cancer Institute. 116 (2024) 6 - p. 812-828 , 2024

Link: https://doi.org/10.1093/..

4

Prevalence of KRAS G12C Mutation and Co-mutations and Assoc..:

Strickler, John H ; Yoshino, Takayuki ; Stevinson, Kendall...
The Oncologist. 28 (2023) 11 - p. e981-e994 , 2023

Link: https://doi.org/10.1093/..

5

Hepatic artery infusion for unresectable colorectal cancer ..:

Zaidi, Mohammad Y. ; Nussbaum, Daniel P. ; Hsu, Shiaowen David...
Surgery. 174 (2023) 2 - p. 428-430 , 2023

Link: https://doi.org/10.1016/..

6

First-in-human study of oleclumab, a potent, selective anti..:

Bendell, Johanna ; LoRusso, Patricia ; Overman, Michael...
Cancer Immunology, Immunotherapy. 72 (2023) 7 - p. 2443-2458 , 2023

Link: https://doi.org/10.1007/..

7

Targeting KRAS-Mutated Gastrointestinal Malignancies with S..:

Caughey, Bennett A. ; Strickler, John H.
Drugs. 84 (2023) 1 - p. 27-44 , 2023

Link: https://doi.org/10.1007/..

8

Circulating Tumor DNA Testing Overcomes Limitations of Comp..:

Kumar, Anivarya ; Green, Michelle ; Thacker, Julie..
Case Reports in Oncology. , 2023

Link: https://doi.org/10.1159/..

9

Impact of Anti-EGFR Therapies on HER2-Positive Metastatic C..:

Bekaii-Saab, Tanios S ; Lach, Krzysztof ; Hsu, Ling-I...
The Oncologist. 28 (2023) 10 - p. 885-893 , 2023

Link: https://doi.org/10.1093/..

10

Tucatinib plus trastuzumab for chemotherapy-refractory, HER..:

Strickler, John H ; Cercek, Andrea ; Siena, Salvatore...
The Lancet Oncology. 24 (2023) 5 - p. 496-508 , 2023

Link: https://doi.org/10.1016/..

11

Management of Microsatellite Instability High (MSI-H) Gastr..:

Zhou, Katherine I. ; Hanks, Brent A. ; Strickler, John H.
Journal of Gastrointestinal Cancer. 55 (2023) 2 - p. 483-496 , 2023

Link: https://doi.org/10.1007/..

12

Concordance Between Genomic Alterations Detected by Tumor a..:

Green, Michelle F ; Watson, Catherine H ; Tait, Sarah...
The Oncologist. 28 (2023) 1 - p. 33-39 , 2023

Link: https://doi.org/10.1093/..

13

Efficacy and Safety of Dilpacimab (ABT-165) versus Bevacizu..:

Strickler, John H ; Cubillo, Antonio ; Liang, Jin-Tung...
Future Oncology. 18 (2022) 27 - p. 3011-3020 , 2022

Link: https://doi.org/10.2217/..

14

Cabozantinib with or without Panitumumab for RAS wild-type ..:

Jia, Jingquan ; Howard, Lauren ; Liu, Yingmiao...
Cancer Chemotherapy and Pharmacology. 89 (2022) 3 - p. 413-422 , 2022

Link: https://doi.org/10.1007/..

15

Genomic and precision medicine. Oncology:

Ginsburg, Geoffrey S ; Willard, Huntington F ; Strickler, John H. - Third edition. . , 2022

Link: https://www.sciencedirec..